A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users

P. Lazarus, H. S. Garewal, J. Sciuuba, N. Zwiebel, A. Calcagnotto, A. Fair, S. Schaefer, J. P. Richie

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

To determine the incidence of pS3 mutations in pre‐malignant lesions of the oral cavity from individuals without prior history of tobacco use, we have analyzed the conserved regions of the pS3 gene (exons 5‐9) in archival oral cavity lesion specimens obtained from patients with varied tobacco use histories, by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) and DNA sequencing analysis. Twenty‐six lesions were analyzed from 14 patients, with multiple lesions obtained from 8 patients. Six of these patients used tobacco, (3 being cigarette smokers, 1 ex‐cigarette smoker, 1 moderate cigar smoker and 1 snuff chewer). The remaining 8 patients had no prior history of tobacco use. Thirteen of the pre‐malignant lesions exhibited severe dysplasia, 9 exhibited moderate dysplasia and 4 exhibited mild dysplasia. Four of the 26 lesions exhibited pS3 mutations, each being from a tobacco user. None of the 13 lesions from never‐tobacco users exhibited pS3 mutations. There was a significantly higher p53 mutation incidence in pre‐malignant lesions from tobacco users (including ex‐smokers) than in non‐tobacco users as well as in cigarette smokers plus snuff chewers than in non‐tobacco users. Two of the mutations were observed in lesions exhibiting severe dysplasia: I in a lesion exhibiting moderate dysplasia and I in a lesion exhibiting mild dysplasia. These data suggest that pS3 mutation may be a very early event in oral cavity tumor progression and demonstrate that pre‐malignant lesions obtained from non‐tobacco users do not exhibit pS3 mutations.

Original languageEnglish (US)
Pages (from-to)458-463
Number of pages6
JournalInternational Journal of Cancer
Volume60
Issue number4
DOIs
StatePublished - Feb 8 1995

Fingerprint

Mouth
Mutation
Incidence
Tobacco Use
Tobacco Products
Tobacco
Smokeless Tobacco
DNA Sequence Analysis
Exons
Polymerase Chain Reaction
Genes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Lazarus, P. ; Garewal, H. S. ; Sciuuba, J. ; Zwiebel, N. ; Calcagnotto, A. ; Fair, A. ; Schaefer, S. ; Richie, J. P. / A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users. In: International Journal of Cancer. 1995 ; Vol. 60, No. 4. pp. 458-463.
@article{33ee3a3d395146ac8146cfb5d72d99db,
title = "A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users",
abstract = "To determine the incidence of pS3 mutations in pre‐malignant lesions of the oral cavity from individuals without prior history of tobacco use, we have analyzed the conserved regions of the pS3 gene (exons 5‐9) in archival oral cavity lesion specimens obtained from patients with varied tobacco use histories, by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) and DNA sequencing analysis. Twenty‐six lesions were analyzed from 14 patients, with multiple lesions obtained from 8 patients. Six of these patients used tobacco, (3 being cigarette smokers, 1 ex‐cigarette smoker, 1 moderate cigar smoker and 1 snuff chewer). The remaining 8 patients had no prior history of tobacco use. Thirteen of the pre‐malignant lesions exhibited severe dysplasia, 9 exhibited moderate dysplasia and 4 exhibited mild dysplasia. Four of the 26 lesions exhibited pS3 mutations, each being from a tobacco user. None of the 13 lesions from never‐tobacco users exhibited pS3 mutations. There was a significantly higher p53 mutation incidence in pre‐malignant lesions from tobacco users (including ex‐smokers) than in non‐tobacco users as well as in cigarette smokers plus snuff chewers than in non‐tobacco users. Two of the mutations were observed in lesions exhibiting severe dysplasia: I in a lesion exhibiting moderate dysplasia and I in a lesion exhibiting mild dysplasia. These data suggest that pS3 mutation may be a very early event in oral cavity tumor progression and demonstrate that pre‐malignant lesions obtained from non‐tobacco users do not exhibit pS3 mutations.",
author = "P. Lazarus and Garewal, {H. S.} and J. Sciuuba and N. Zwiebel and A. Calcagnotto and A. Fair and S. Schaefer and Richie, {J. P.}",
year = "1995",
month = "2",
day = "8",
doi = "10.1002/ijc.2910600406",
language = "English (US)",
volume = "60",
pages = "458--463",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

Lazarus, P, Garewal, HS, Sciuuba, J, Zwiebel, N, Calcagnotto, A, Fair, A, Schaefer, S & Richie, JP 1995, 'A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users', International Journal of Cancer, vol. 60, no. 4, pp. 458-463. https://doi.org/10.1002/ijc.2910600406

A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users. / Lazarus, P.; Garewal, H. S.; Sciuuba, J.; Zwiebel, N.; Calcagnotto, A.; Fair, A.; Schaefer, S.; Richie, J. P.

In: International Journal of Cancer, Vol. 60, No. 4, 08.02.1995, p. 458-463.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users

AU - Lazarus, P.

AU - Garewal, H. S.

AU - Sciuuba, J.

AU - Zwiebel, N.

AU - Calcagnotto, A.

AU - Fair, A.

AU - Schaefer, S.

AU - Richie, J. P.

PY - 1995/2/8

Y1 - 1995/2/8

N2 - To determine the incidence of pS3 mutations in pre‐malignant lesions of the oral cavity from individuals without prior history of tobacco use, we have analyzed the conserved regions of the pS3 gene (exons 5‐9) in archival oral cavity lesion specimens obtained from patients with varied tobacco use histories, by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) and DNA sequencing analysis. Twenty‐six lesions were analyzed from 14 patients, with multiple lesions obtained from 8 patients. Six of these patients used tobacco, (3 being cigarette smokers, 1 ex‐cigarette smoker, 1 moderate cigar smoker and 1 snuff chewer). The remaining 8 patients had no prior history of tobacco use. Thirteen of the pre‐malignant lesions exhibited severe dysplasia, 9 exhibited moderate dysplasia and 4 exhibited mild dysplasia. Four of the 26 lesions exhibited pS3 mutations, each being from a tobacco user. None of the 13 lesions from never‐tobacco users exhibited pS3 mutations. There was a significantly higher p53 mutation incidence in pre‐malignant lesions from tobacco users (including ex‐smokers) than in non‐tobacco users as well as in cigarette smokers plus snuff chewers than in non‐tobacco users. Two of the mutations were observed in lesions exhibiting severe dysplasia: I in a lesion exhibiting moderate dysplasia and I in a lesion exhibiting mild dysplasia. These data suggest that pS3 mutation may be a very early event in oral cavity tumor progression and demonstrate that pre‐malignant lesions obtained from non‐tobacco users do not exhibit pS3 mutations.

AB - To determine the incidence of pS3 mutations in pre‐malignant lesions of the oral cavity from individuals without prior history of tobacco use, we have analyzed the conserved regions of the pS3 gene (exons 5‐9) in archival oral cavity lesion specimens obtained from patients with varied tobacco use histories, by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP) and DNA sequencing analysis. Twenty‐six lesions were analyzed from 14 patients, with multiple lesions obtained from 8 patients. Six of these patients used tobacco, (3 being cigarette smokers, 1 ex‐cigarette smoker, 1 moderate cigar smoker and 1 snuff chewer). The remaining 8 patients had no prior history of tobacco use. Thirteen of the pre‐malignant lesions exhibited severe dysplasia, 9 exhibited moderate dysplasia and 4 exhibited mild dysplasia. Four of the 26 lesions exhibited pS3 mutations, each being from a tobacco user. None of the 13 lesions from never‐tobacco users exhibited pS3 mutations. There was a significantly higher p53 mutation incidence in pre‐malignant lesions from tobacco users (including ex‐smokers) than in non‐tobacco users as well as in cigarette smokers plus snuff chewers than in non‐tobacco users. Two of the mutations were observed in lesions exhibiting severe dysplasia: I in a lesion exhibiting moderate dysplasia and I in a lesion exhibiting mild dysplasia. These data suggest that pS3 mutation may be a very early event in oral cavity tumor progression and demonstrate that pre‐malignant lesions obtained from non‐tobacco users do not exhibit pS3 mutations.

UR - http://www.scopus.com/inward/record.url?scp=0028950119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028950119&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910600406

DO - 10.1002/ijc.2910600406

M3 - Article

C2 - 7829258

AN - SCOPUS:0028950119

VL - 60

SP - 458

EP - 463

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -